SM
Sabby Management Portfolio holdings
AUM
$19.3M
1-Year Est. Return
30.81%
1 Year Est. Return
-30.81%
AUM
$13M
AUM Growth
-$10.8M
(-45%)
Holding
60
Top Buys
| 1 | +$1.88M | |
| 2 | +$1.13M | |
| 3 | +$1.01M | |
| 4 |
CANF
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CANF
|
+$819K |
| 5 |
Imunon
IMNN
|
+$720K |
Top Sells
| 1 | +$4.72M | |
| 2 | +$4.12M | |
| 3 | +$2.82M | |
| 4 |
Eos Energy Enterprises
EOSE
|
+$1.76M |
| 5 |
Knightscope
KSCP
|
+$1.25M |
Sector Composition
| 1 | Healthcare | 55.11% |
| 2 | Industrials | 20.02% |
| 3 | Financials | 5.93% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Technology | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGMK
51
DELISTED
LogicMark
LGMK
| – | – |
-7,044,022
|
|
||
52
Eli Lilly
LLY
$961B
| – | – |
-3,420
|
|
||
53
NovaBay Pharmaceuticals
NBY
$1.6B
| – | – |
-218,045
|
|
||
54
Nano X Imaging
NNOX
$197M
| – | – |
-26,146
|
|
||
55
iShares S&P 100 ETF
OEF
$29.2B
| – | – |
0
|
|
||
56
TransCode Therapeutics
RNAZ
$8.27M
| – | – |
-8,180
|
|
||
57
Sidus Space
SIDU
$245M
| – | – |
-24,186
|
|
||
58
SPDR S&P 500 ETF Trust
SPY
$713B
| – | – |
-1,190
|
|
||
59
Surf Air Mobility
SRFM
$175M
| – | – |
-1,766,151
|
|
||
60
Sharps Technology
STSS
$63.2M
| – | – |
-39,074
|
|